Laboratory reports, sometimes called certificates of analysis or COAs, are the most reliable piece of evidence about what is inside a cannabis or hemp product. For consumers, retailers, and clinicians, a readable COA separates useful products from empty marketing claims. For producers, the report is a tool for quality control and liability management. This guide walks through the sections you will actually use, the numbers that matter, and the traps that let testing results mislead. Expect practical examples, real trade-offs, and specific things to check on every time.
Why lab reports matter Lab reports translate chemistry into action. If you want a predictable dose of a specific cannabinoid, detect contaminants before use, or validate a product labeled as hemp, the COA is where that information lives. I have reviewed hundreds of reports while sourcing products and advising manufacturers. Over time a handful of recurring mistakes emerge: mislabeled doses, absent batch numbers, nonaccredited labs, and reports that omit limits of detection. Learning to read a COA lets you spot those issues quickly.
Where to find a report and what to expect Most reputable brands publish a COA on their product page or provide one on request. Some attach a QR code on packaging that links to the report. If the report is not readily available, treat that as a red flag. Expect the COA to be a multi-page PDF that identifies the sample, lists test methods, shows results with units, and provides lab contact information.
A common structure you will see Laboratory reports vary in layout, but they generally include sample identification, cannabinoid potency, terpene profile, contaminants testing, method details, accreditation, and signature. The order may differ, but those elements should appear somewhere in the file.
Decoding the title block and sample ID Start at the top. The title block gives context you need to judge relevance. Confirm these items:
- sample name and product SKU: does it match the bottle or package you have? batch or lot number: many problems are batch specific. collection date and test date: degradation can occur; a sample tested months before sale may no longer match current inventory. sample weight or volume: some labs list how much material they tested; a tiny subsample may not represent the whole batch.
If any of these are missing or inconsistent, push for clarification. I once audited a small producer whose COAs had dates that predated the batch by several months. The explanation was sloppy recordkeeping, but it could also mask a substitute sample. Ministry of Cannabis Good recordkeeping matters.
Reading the cannabinoid potency section Potency is the headline everyone reads. This section lists individual cannabinoids with concentrations and units. Key points to understand:
- units are usually mg/g or mg/mL, sometimes % weight by weight. For example, 10 mg/g equals 1% w/w. total THC and total CBD often include acidic precursors. Labs report THCa and THC separately and also show a calculated total THC that accounts for decarboxylation. Be sure you know which number the label used. minor cannabinoids show up with lower concentrations but matter for effect and regulation. Look for CBG, CBC, CBDV, and delta-8 or delta-9 depending on the product.
Example interpretation If a tincture lists CBD 250 mg per bottle on the label and the COA shows CBD 248 mg per bottle, that is good alignment. If the COA shows CBD 150 mg and the label says 250 mg, that is a mismatch and an indication of under-dosing or labeling fraud.
Understanding total THC for legal compliance For hemp products, the regulatory threshold often referenced is 0.3% total THC on a dry weight basis. Laboratories calculate total THC by adding THCa times a conversion factor plus delta-9 THC. The exact calculation varies, but the effect is to reflect the potential THC after decarboxylation. If the calculated total THC is close to the regulatory threshold, small analytical differences or sample heterogeneity can matter. Producers should test multiple units across a batch when they are near the legal limit.
Terpenes and why they show up Terpenes are responsible for aroma and can influence perception of effect. A terpene panel lists compounds by name and concentration, typically in mg/g or percent. Terpene content is useful for sensory expectations and for matching strain profiles, but be cautious when companies imply strong therapeutic differences based solely on terpene numbers. Terpenes are volatile; storage and handling change the profile quickly. If a product claims a particular aroma but the terpene report is near zero, the product may be overprocessed or oxidized.
Contaminants testing - what to take seriously Contaminant panels vary by state and by country. Typical categories include pesticides, heavy metals, residual solvents, mycotoxins, and microbial burden. Prioritize these results because contamination carries real health risk.
Pesticides Look for a clear list of tested pesticides and the limits used. A pass/fail remark is less useful than numerical concentrations alongside the lab's limit of detection or regulatory action level. If a pesticide is detected at trace levels, check whether it exceeds the regulatory limit for your jurisdiction.
Heavy metals Reports usually list arsenic, cadmium, lead, and mercury. Results should be given in parts per million or parts per billion with reporting limits. For inhalable products such as vape cartridges, acceptable limits are often tighter than for edibles.
Residual solvents Extraction solvents like butane, ethanol, or propane should be below established limits. If a solvent is listed as detected, check the concentration relative to the acceptable limit. High solvent levels suggest inadequate purge after extraction.
Microbial and mycotoxin testing Test reports should indicate whether total yeast and mold counts and specific pathogens such as E. Coli or Salmonella were tested. For flower, visible mold is a separate issue from lab detection. For immunocompromised users, even low counts matter.
Moisture and homogeneity Water activity or moisture content sometimes appears. High moisture increases the risk of microbial growth. Homogeneity is rarely reported, but manufacturers should validate that active ingredients are evenly distributed across units. Absence of homogeneity testing increases the chance of dose variance.
Methods, accreditation, and what they mean The bottom of the report should show which methods were used and whether the lab is accredited. Method names tell you about reliability.
Analytical method labels to watch High performance liquid chromatography with diode array detection is commonly abbreviated as HPLC-DAD and is standard for cannabinoids and many terpenes. Gas chromatography mass spectrometry is common for residual solvents and some pesticide analyses. Liquid chromatography tandem mass spectrometry, LC-MS/MS, is the workhorse for sensitive pesticide and mycotoxin detection.
Accreditation ISO 17025 accreditation or state-equivalent accreditation indicates the lab follows recognized quality systems. Accreditation does not guarantee perfection, but a nonaccredited lab requires greater scrutiny. If a lab is accredited, the report should reference the accreditation body and a certificate number.
Limits of detection and quantitation Every test has a blind spot. Reports should list the limit of detection and the limit of quantitation for each analyte. If a cannabinoid or contaminant is reported as non-detect, check the detection limit. A non-detect result with a high detection limit is not as reassuring as a non-detect with a low detection limit.
Batch representativeness and sampling Sampling strategy matters more than many buyers realize. A report is only as representative as the sample collected. For large batches, a single sample may not represent the whole. Look for language describing how the sample was taken. If no sampling plan is documented, assume higher risk.
Red flags to watch for A few patterns tend to indicate unreliable or manipulated reports.
- missing batch number or sample description that does not match the product dates that do not align with manufacturing or sale dates results with many values exactly at limit numbers, which can suggest rounding or manipulation lack of method or accreditation information only a single cannabinoid reported when the product should naturally contain others
Practical steps to verify a report If you want a quick procedure to verify a COA, follow these steps:
Confirm product details and batch number match your item Check test dates to ensure the report applies to the batch you have Verify the lab accreditation and noted methods Scan cannabinoid totals and compare label claims Examine contaminant results and reported detection limitsThis five-step checklist covers most use cases you will encounter. If any step raises concern, request a clarification from the vendor or ask for a COA for a different unit in the same batch.
Case examples from practice Example 1 - underlabeled potency A retail buyer once sent me a tincture COA that listed CBD at 60 mg per bottle while the label promised 300 mg. The seller had repackaged a bulk-tincture concentrate into smaller bottles without adjusting the label. Customers experienced little effect. The remedy was to test multiple bottles from the lot and pursue a recall for mislabeling.
Example 2 - borderline legal THC A small hemp farmer sold flower that tested at 0.28% total THC in an initial assay. Batch-to-batch variability and calculation differences created risk for exceeding the 0.3% threshold. The farmer adjusted cultivation and harvesting parameters to reduce THCa formation and instituted more frequent testing to avoid a potential legal problem.
Example 3 - solvent residue issue An extractor purchased a new solvent system and one batch of distillate failed residual solvent testing for butane. They traced the issue to inadequate purge temperature and corrected the process. That COA prevented the product from shipping.
How to communicate findings to vendors or labs If you find a questionable result, approach the vendor with specific, documented points. Ask for the raw chromatograms or test certificates for neighboring batches. Reputable labs will provide chromatograms on request and explain method validation parameters. If the vendor stonewalls, treat that as a signal to avoid the product.
Edge cases and trade-offs There are situations where the COA does not give a clear answer. For example, an artisanal smoked product may have nonuniform distribution of cannabinoids in individual cigarettes. Testing whole sticks is often impractical, so manufacturers test bulk and provide averages. That is a trade-off between feasibility and precision. Similarly, terpene loss over time means a COA taken shortly after production may not reflect the product at point of sale.
Regulatory differences by use case Different product categories face different standards. Vape cartridges and inhalable concentrates have tighter limits for solvents and metals because of lung exposure. Edibles often have tighter microbial limits and different pesticide action levels. Know the use case when judging a COA.
Questions clinicians and patients should ask Clinicians advising patients and individuals using cannabinoid products should ask: Does the COA show the specific cannabinoid needed? Is total THC below the jurisdictional limit for hemp products? Are contaminants within safe ranges for the intended route of administration? For immunocompromised patients, ask specifically about microbial testing. For inhalation, inspect solvent and metal results carefully.
A short guide for retailers and purchasers Retailers and bulk purchasers have additional responsibilities. Track COAs by lot and ensure incoming shipments have matching reports. Perform spot testing from shelf inventory if your regulator requires it. Train staff to read the COA and flag mismatches immediately. Maintain a simple inventory of COA links and batch numbers for traceability.
Final practical tips Keep a folder, digital or physical, with COAs for every product batch you handle. When possible, ask the lab for raw data or chromatograms if you need to verify a suspicious value. Use the five-step checklist above as your default triage. Accept that chemistry is imperfect; look for patterns rather than a single outlier.
Reading lab reports for cannabinoids is not merely a technical exercise. It is due diligence that protects consumers and preserves trust in a market that still struggles with inconsistent standards. With an eye for sample identity, methods, detection limits, and contaminants, you can separate meaningful safety and potency information from marketing noise.